Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

UBIPACS

K-Number: K042507 · 2004-09-27

ApplicantIcm Co., Ltd.
Decision Date2004-09-27
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

UBIPACS is the device name listed in this FDA 510(k) record. The listed applicant is Icm Co., Ltd.. It received FDA 510(k) clearance on 2004-09-27 under 510(k) number K042507. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the UBIPACS?

UBIPACS is a medical device that received FDA 510(k) clearance on 2004-09-27. The listed applicant is Icm Co., Ltd.. The 510(k) number is K042507.

When did UBIPACS receive FDA 510(k) clearance?

UBIPACS received FDA 510(k) clearance on 2004-09-27, under 510(k) number K042507.

Who is the listed applicant for UBIPACS?

The FDA 510(k) record lists Icm Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for UBIPACS?

The FDA product code for UBIPACS is LLZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑